Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sopheon Announces Agreement to Acquire Alignent Software

11 Jun 2007 14:30

Sopheon, the international software and services company,announced today that it has signed a definitive agreement to acquireAlignent Software Inc. The cash-based transaction is expected to becompleted on or about June 18, 2007. £ Based in California, Alignent is one of only a few suppliersworldwide that specializes in the provision of advanced product andtechnology roadmapping software for complex global companies.Alignent's flagship offering, Vision Strategist, is generallyrecognized as the leading application of its kind. The software has aproven track record of helping large organizations improve strategicinnovation planning. Some of the foremost aerospace, defense andhigh-tech companies in the world, including Boeing, BAE Systems,Corning, Honeywell, Lockheed Martin, Motorola and NAVAIR have adoptedAlignent's offering as their product planning solution. £ Alignent's roadmapping software is an ideal complement toSopheon's existing product innovation process and portfolio managementsystem. Vision Strategist allows the user to visualize and predict howexternal market and technology trends will impact product plans overtime, enabling better decisions on future product direction. Aprincipal advantage of the software is that it improvescross-functional communication and collaboration throughout theplanning process. Sopheon's Accolade(R) software enhances theexecution of product plans by automating innovation processgovernance. Although the two applications will continue to be marketedseparately, together they will constitute industry's first end-to-endstrategic product planning software suite. £ The acquisition of Alignent will immediately expand Sopheon'sbusiness in two areas. First, for the company's nearly 100 existingclients in chemical and consumer packaged goods markets, it willextend Sopheon's solution to include strategic product planning.Secondly, Alignent's roster of industry-leading customers will giveSopheon instant credibility in a range of new markets, acceleratingits entry into aerospace, defense and high-tech. £ Sopheon estimates that the acquisition will advance its productplans for Accolade by a full two years. It will also result in asubstantial increase in the size of Sopheon's customer base. Initialfeedback indicates that Sopheon can expect to achieve significantorganic growth by selling its Accolade solution to existing Alignentclients challenged with improving innovation process governance.Sopheon expects to begin offering Accolade's product portfoliomanagement capabilities to Alignent customers this summer. £ "Our acquisition of Alignent represents significant strategicvalue to Sopheon," said Barry Mence, Sopheon's chairman. "It will helpus deepen our penetration in the chemicals and consumer goods marketswe currently target, while accelerating our expansion into new marketssuch as aerospace, defense and high-tech, which offer great upsidegrowth potential. We expect substantial near- and long-term revenuebenefits from the transaction, as well as enhanced earnings on anongoing basis. This is a very positive move for our company, for ourclients and for our shareholders." £ "Sopheon has already established strong market position as thepremier provider of software applications for governance of theinnovation process," said Dennis Clerke, chief executive officer ofAlignent. "The addition of Alignent's products, people and partnerswill enable Sopheon to deliver an unmatched set of strategic productplanning and execution solutions to business and R&D decision makers.This is an exciting development that will yield significant benefitsnot only to Alignent's customers, but to global manufacturers in allsectors of industry." £ Alignent reported revenues of $3 million and a $4.3 million netoperating loss for 2006. Completion of the transaction is contingentupon the receipt of consents from Alignent shareholders and thedelivery of ancillary agreements and formalities. Gross considerationfor the acquisition amounts to $5.5 million, including $4.75 millioninitially upon closing and an additional $750 thousand in potentialearn-out payments. Sopheon expects the Alignent business to make apositive EBITDA contribution from the first year following thepurchase. £ Accolade(R) is a registered trademark of Sopheon plc. £ All other trademarks and registered trademarks are the soleproperty of their respective owners. £ About Alignent Software £ Alignent software company supports the powerful process ofroadmapping. Alignent's solutions dynamically connect product andtechnology planning across the company, empowering organizations tovisualize, manage and communicate future directions within a singlesystem. Alignent focuses R&D efforts, fosters cross-functionalcollaboration and aligns people around a unified plan of record thatadapts in real-time to empower accurate, timely business decisions.The world's most sophisticated product and technology planners rely onAlignent, including BAE Systems, Corning, Honeywell, Lockheed Martin,Medtronic, Motorola, Philips, Textron, the U.S. Air Force and the U.S.Navy. For more information, please visit www.alignent.com. £ About Sopheon £ Sopheon (LSE:SPE) is an international provider of software andservices that help organizations improve the business impact ofproduct innovation. Sopheon's Accolade system automates and governsthe innovation process, enabling companies to increase revenue andprofits from new products. Sopheon is listed on the AIM Market of theLondon Stock Exchange and on the Euronext in the Netherlands. For moreinformation, please visit www.sopheon.com. Copyright Business Wire 2007
Date   Source Headline
6th Dec 20137:00 amRNSDirector/PDMR Shareholding
5th Dec 20137:00 amRNSCorporate Update
19th Nov 20137:00 amRNSSopheon Delivers Accolade® Release 9.0
7th Nov 20137:00 amRNSInterim Management Statement
11th Sep 20133:00 pmRNSHolding(s) in Company
4th Sep 20133:00 pmRNSHolding(s) in Company
22nd Aug 20137:00 amRNSInterim Results
15th Aug 20133:00 pmRNSHolding(s) in Company
29th Jul 20133:00 pmRNSHolding(s) in Company
26th Jul 20137:00 amRNSTrading Update
15th Jul 20134:15 pmRNSHolding(s) in Company
28th Jun 20133:00 pmRNSTotal Voting Rights
27th Jun 20133:00 pmRNSHolding(s) in Company
19th Jun 20133:42 pmRNSHolding(s) in Company
19th Jun 20137:00 amRNSNew capabilities with Accolade(R) 8.3
14th Jun 20132:00 pmRNSContract Win
12th Jun 201312:00 pmRNSResult of AGM & GM
12th Jun 20137:00 amRNSAGM Statement
4th Jun 20137:00 amRNSIssue of Shares
2nd May 20137:00 amRNSInterim Management Statement
21st Mar 20137:00 amRNSPreliminary Results
30th Jan 20137:00 amRNSTrading Update
23rd Jan 20137:00 amRNSLaunch of Accolade 8.2
7th Dec 201211:36 amPRNHolding(s) in Company
8th Nov 20127:00 amPRNInterim Management Statement
1st Oct 20127:00 amRNSHolding(s) in Company
1st Oct 20127:00 amRNSDirectors' Options
24th Sep 20127:00 amRNSMarket Transfer to NYSE Alternext Concluded
23rd Aug 20127:00 amRNSAmendment to Terms of Convertible Loan Stock
23rd Aug 20127:00 amRNSInterim Results
23rd Jul 20127:00 amRNSTrading Update
13th Jun 20123:14 pmRNSResult of AGM
13th Jun 20127:00 amRNSAGM Statement
15th May 20127:00 amRNSAmendment to terms of Convertible Loan Stock
3rd May 20127:00 amRNSInterim Management Statement
25th Apr 20127:00 amRNSLaunch of Accolade 8.0
22nd Mar 20127:00 amRNSPreliminary Results
16th Feb 20127:00 amRNSTop 10 Solution Provider to CGM
31st Jan 20127:00 amRNSTrading Update
23rd Dec 201112:32 pmRNSExtension of GEM Equity Line
23rd Dec 201112:29 pmRNSTrading Update
5th Dec 201112:40 pmRNSHolding(s) in Company
3rd Nov 20117:00 amRNSInterim Management Statement
25th Aug 20117:00 amRNSInterim Results
25th Jul 20117:00 amRNSTrading Statement
23rd Jun 20112:15 pmRNSDirector/PDMR Shareholding
15th Jun 20117:00 amRNSAGM Statement
5th May 20117:00 amRNSInterim Management Statement
24th Mar 20117:00 amRNSPreliminary Results
10th Feb 20117:00 amPRNAppointment of Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.